Prescribing of digoxin for long-term use in atrial fibrillation in France, Germany and the UK during 2000-2014

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/32487
• EU PAS number:
  EUPAS32486
• Study ID:
  32487
• Official title and acronym:
  Prescribing of digoxin for long-term use in atrial fibrillation in France, Germany and the UK during 2000-2014
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany
• Study description:
  This study analyses prescribing of digoxin between 2000 and 2014 and focuses on patients with atrial fibrillation. The study includes overall digoxin prescribing, digoxin prescribing in patients with atrial fibrillation, and digoxin prescribing in patients with atrial fibrillation without heart failure. Results are analysed by gender and age group (75 years or older and less than 75 years).
• Study status:
  Finalised

Research institution and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 02/05/2015

Actual: 02/05/2015

Study start date

Planned: 22/05/2015

Actual: 22/05/2015

Data analysis start date

Planned: 02/06/2015

Actual: 02/06/2015

Date of final study report

Planned: 17/06/2015

Actual: 17/06/2015

Sources of funding

EMA

Study protocol

Initial protocol

Digoxin Protocol_20150617_001

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable